Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
NTRA Natera
- 166.550
- +0.100+0.06%
Close Dec 13 16:00 ET
- 166.220
- -0.330-0.20%
Post 20:01 ET
21.99BMarket Cap-94.63P/E (TTM)
168.985High163.810Low1.21MVolume168.200Open166.450Pre Close200.78MTurnover0.95%Turnover RatioLossP/E (Static)132.02MShares175.63052wk High25.03P/B21.22BFloat Cap57.22052wk Low--Dividend TTM127.42MShs Float175.630Historical High--Div YieldTTM3.11%Amplitude6.520Historical Low165.774Avg Price1Lot Size
About Natera Company
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Company Profile
SymbolNTRA
Company NameNatera
Listing DateJul 2, 2015
Issue Price18.00
Founded2003
CEOMr. Steven Leonard Chapman
MarketNASDAQ
Employees3293
Fiscal Year Ends12-31
AddressBuilding A, 13011 McCallen Pass,Suite 100
CityAustin
ProvinceTexas
CountryUnited States of America
Zip Code78753
Phone1-650-980-9190
Websitehttp://www.natera.com
Company Executives
- Name
- Position
- Salary
- Steven Leonard Chapman
- Director, Chief Executive Officer and Co-President
- 12.73M
- Daniel Rabinowitz
- Secretary and Chief Legal Officer
- 3.33M
- John Fesko
- Co-President and Chief Business Officer
- --
- Michael Brophy
- Chief Financial Officer and Principal Accounting Officer
- 5.07M
- Dr. Matthew Rabinowitz
- Executive Chairman of the Board
- 8.97M
- Solomon Moshkevich
- President, Clinical Diagnostics
- --
- Jonathan Sheena
- Director
- --
- Roelof Frederik Botha
- Lead Independent Director
- 350.98K
- Dr. Roy D. Baynes, M.D.,PhD
- Independent Director
- 317.73K
- Ruth W. Brinkley
- Independent Director
- --
- Dr. Rowan E. Chapman, PhD
- Independent Director
- 338.72K
- Dr. James I. Healy, M.D.,PhD
- Independent Director
- 329.64K
- Dr. Gail B. Marcus
- Independent Director
- 337.22K
- Herm Rosenman
- Independent Director
- 339.16K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.